Current Report Filing (8-k)

Date : 06/21/2019 @ 1:01PM
Source : Edgar (US Regulatory)
Stock : Flexion Therapeutics Inc (FLXN)
Quote : 19.53  0.54 (2.84%) @ 4:59AM
After Hours
Last Trade
Last $ 19.32 ▼ -0.21 (-1.08%)

Current Report Filing (8-k)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 19, 2019

 

Flexion Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

001-36287

 

26-1388364

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

10 Mall Road, Suite 301

Burlington, Massachusetts

 


01803

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (781) 305-7777

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

FLXN

The Nasdaq Global Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( § 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( § 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


Ite m 5.07 Submission of Matters to a Vote of Security Holders .

Flexion Therapeutics, Inc. (“Flexion”) held its 2019 Annual Meeting of Stockholders (the “Annual Meeting”) on June 19, 2019. At the Annual Meeting, Flexion’s stockholders (i) elected the three Class II directors to serve on the Board of Directors of Flexion (the “Board”) until Flexion’s 2022 Annual Meeting of Stockholders and until their respective successor has been duly elected and qualified, or, if sooner, until the director’s death, resignation or removal; (ii) ratified the selection, by the Audit Committee of the Board (the “Audit Committee”), of PricewaterhouseCoopers LLP as Flexion’s independent registered public accounting firm for its fiscal year ending December 31, 2019; (iii) approved, on an advisory basis, the compensation of Flexion’s named executive officers, as disclosed in Flexion’s 2019 Proxy Statement; and (iv) indicated, on an advisory basis, that the preferred frequency of stockholder advisory votes on the compensation of Flexion’s named executive officers is on an annual basis. There were 37,992,631  outstanding shares eligible to vote as of April 22, 2019, the record date for the Annual Meeting.

The directors elected to the Board, as well as the number of votes cast for, votes withheld and broker non-votes with respect to each of these individuals, are set forth below:

Director

 

For

 

 

Withheld

 

 

Broker Non-Votes

 

Scott A. Canute

 

 

21,025,714

 

 

 

4,815,243

 

 

 

8,855,869

 

Samuel D. Colella

 

 

19,803,539

 

 

 

6,037,418

 

 

 

8,855,869

 

Mark Stejbach

 

 

21,132,421

 

 

 

4,708,536

 

 

 

8,855,869

 

The proposal to ratify the selection by the Audit Committee of PricewaterhouseCoopers LLP as Flexion’s independent registered public accounting firm for its fiscal year ending December 31, 2019 received the following votes:

For

 

 

Against

 

 

Abstentions

 

 

Broker Non-Votes

 

 

 

34,537,196

 

 

106,174

 

 

53,456

 

 

0

 

 

 

 

 

 

The proposal to approve, on an advisory basis, the compensation of Flexion’s named executive officers, as disclosed in the 2019 Proxy Statement received the following votes:   

 

For

 

 

Against

 

 

Abstentions

 

 

Broker Non-Votes

 

 

 

21,947,138

 

 

3,823,044

 

 

70,775

 

 

8,855,869

 

 

 

 

 

 

 

 

The advisory vote on preferred frequency of stockholder advisory votes on the compensation of Flexion’s named executive officers received the following votes:

 

1 Year

 

2 Years

 

 

3 Years

 

 

Abstentions

 

 

Broker Non-Votes

25,626,766

 

 

95,222

 

 

 

90,744

 

 

 

28,225

 

 

8,855,869

 

 

Consistent with the preference of Flexion’s stockholders indicated by the voting results for the advisory vote on preferred frequency of stockholder advisory votes on the compensation of Flexion’s named executive officers, Flexion will include a stockholder advisory vote on the compensation of Flexion’s named executive officers every year until the next required vote on the frequency of such advisory votes.

 

 

Each of the foregoing voting results from the Annual Meeting is final.



 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

 

 

 

 

Flexion Therapeutics, Inc.

 

 

 

 

Dated: June 21, 2019

 

 

 

By:

 

/s/ Mark S. Levine

 

 

 

 

 

 

Mark S. Levine

General Counsel and Corporate Secretary

 

Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart

1 Year : From Dec 2018 to Dec 2019

Click Here for more Flexion Therapeutics Charts.

Flexion Therapeutics (NASDAQ:FLXN)
Intraday Stock Chart

Today : Saturday 7 December 2019

Click Here for more Flexion Therapeutics Charts.

Latest FLXN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.